MoneyWorks4Me

Concord Drugs - Quaterly Results

18 Oct 2021 Evaluate
A decrease of about -40.65% in the sales to Rs. 98.59 millions was observed for the quarter ended September 2021. The sales stood at Rs. 166.12 millions during the similar quarter previous year.The Net Profit of the company vaulted to 458.54% to Rs. 4.58  millions from Rs. 0.82 millions in the previous quarter.Operating profit surged to 16.67 millions from the corresponding previous quarter of 9.29 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 98.59 166.12 -40.65 301.00 348.37 -13.60 514.52 514.59 -0.01
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 16.67 9.29 79.44 39.56 19.09 107.23 33.15 34.65 -4.33
Interest 3.06 4.89 -37.42 12.64 9.28 36.21 14.20 15.44 -8.03
PBDT 13.61 4.40 209.32 26.92 9.81 174.41 56.58 19.21 194.53
Depreciation 5.67 3.30 71.82 10.99 6.47 69.86 13.65 14.64 -6.76
PBT 7.94 1.10 621.82 15.93 3.34 376.95 42.93 4.57 839.39
TAX 3.36 0.28 1100.00 4.49 0.86 422.09 10.10 1.28 689.06
Deferred Tax 0.59 0.11 436.36 -0.75 0.15 -600.00 5.40 0.09 5900.00
PAT 4.58 0.82 458.54 11.44 2.48 361.29 32.83 3.29 897.87
Equity 87.44 87.44 0.00 87.44 87.44 0.00 87.44 87.44 0.00
PBIDTM(%) 16.91 5.59 202.35 13.14 5.48 139.84 6.44 6.73 -4.32
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..